Teva Pharmaceutical US Affiliate, Alvotech Selarsdi Injection Now Available in US

MT Newswires Live

Feb 21, 2025

Teva Pharmaceutical Industries (TEVA) US affiliate and Alvotech (ALVO) said Friday that the Selarsdi injection is now available in the US to treat psoriatic arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, pediatric plaque psoriasis and pediatric psoriatic arthritis.

Selarsdi is biosimilar to Stelara and it is the second biosimilar now available in the country under the Teva and Alvotech collaboration, they added.

The US Food and Drug Administration provisionally determined that Selarsdi is interchangeable with the reference biologic Stelara after the first interchangeable biosimilar expires, on April 30, the parties said.

Teva Pharmaceutical's stock rose 2.7%, while Alvotech's shares were up 3% in recent Friday premarket activity.

Price: 17.46, Change: +0.46, Percent Change: +2.71

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2513269747"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2513269747\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2513269747?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-21 19:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2513269747","market":"hk","top_or_hot":-1,"title":"Teva Pharmaceutical US Affiliate, Alvotech Selarsdi Injection Now Available in US","media":"MT Newswires Live","content":"<html><body><p> Teva Pharmaceutical Industries (TEVA) US affiliate and <a href=\"https://laohu8.com/S/ALVO\">Alvotech</a> (ALVO) said Friday that the Selarsdi injection is now available in the US to treat psoriatic arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, pediatric plaque psoriasis and pediatric psoriatic arthritis.</p><p>Selarsdi is biosimilar to Stelara and it is the second biosimilar now available in the country under the Teva and Alvotech collaboration, they added.</p><p>The US Food and Drug Administration provisionally determined that Selarsdi is interchangeable with the reference biologic Stelara after the first interchangeable biosimilar expires, on April 30, the parties said.</p><p>Teva Pharmaceutical's stock rose 2.7%, while Alvotech's shares were up 3% in recent Friday premarket activity.</p><p>Price: 17.46, Change: +0.46, Percent Change: +2.71</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Teva Pharmaceutical US Affiliate, Alvotech Selarsdi Injection Now Available in US</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTeva Pharmaceutical US Affiliate, Alvotech Selarsdi Injection Now Available in US\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-21 19:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Teva Pharmaceutical Industries (TEVA) US affiliate and <a href=\"https://laohu8.com/S/ALVO\">Alvotech</a> (ALVO) said Friday that the Selarsdi injection is now available in the US to treat psoriatic arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, pediatric plaque psoriasis and pediatric psoriatic arthritis.</p><p>Selarsdi is biosimilar to Stelara and it is the second biosimilar now available in the country under the Teva and Alvotech collaboration, they added.</p><p>The US Food and Drug Administration provisionally determined that Selarsdi is interchangeable with the reference biologic Stelara after the first interchangeable biosimilar expires, on April 30, the parties said.</p><p>Teva Pharmaceutical's stock rose 2.7%, while Alvotech's shares were up 3% in recent Friday premarket activity.</p><p>Price: 17.46, Change: +0.46, Percent Change: +2.71</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4559","symbol_name":"巴菲特持仓","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2513269747","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2513269747","pubTimestamp":1740138562,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Teva Pharmaceutical Industries  US affiliate and Alvotech  said Friday that the Selarsdi injection is now available in the US to treat psoriatic arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, pediatric plaque psoriasis and pediatric psoriatic arthritis.Selarsdi is biosimilar to Stelara and it is the second biosimilar now available in the country under the Teva and Alvotech collaboration, they added.The US Food and Drug Administration provisionally determined that Selarsdi is interchangeable with the reference biologic Stelara after the first interchangeable biosimilar expires, on April 30, the parties said.Teva Pharmaceutical's stock rose 2.7%, while Alvotech's shares were up 3% in recent Friday premarket activity.Price: 17.46, Change: +0.46, Percent Change: +2.71","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4559":"巴菲特持仓","BK4596":"哈里斯概念","BK4007":"制药","BK4584":"避孕概念","TEVA":"梯瓦制药","BK4566":"资本集团","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4557":"大麻股","BK4139":"生物科技","ALVO":"Alvotech"},"translate_title":"梯瓦制药美国子公司Alvotech Selarsdi注射液现已在美国上市","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEVA":1,"ALVO":1},"content_text":"Teva Pharmaceutical Industries (TEVA) US affiliate and Alvotech (ALVO) said Friday that the Selarsdi injection is now available in the US to treat psoriatic arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, pediatric plaque psoriasis and pediatric psoriatic arthritis.Selarsdi is biosimilar to Stelara and it is the second biosimilar now available in the country under the Teva and Alvotech collaboration, they added.The US Food and Drug Administration provisionally determined that Selarsdi is interchangeable with the reference biologic Stelara after the first interchangeable biosimilar expires, on April 30, the parties said.Teva Pharmaceutical's stock rose 2.7%, while Alvotech's shares were up 3% in recent Friday premarket activity.Price: 17.46, Change: +0.46, Percent Change: +2.71","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}